{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:28:14Z","timestamp":1789784894702,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Radius Health Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bone.2019.04.025","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T03:33:22Z","timestamp":1556595202000},"page":"148-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis"],"prefix":"10.1016","volume":"124","author":[{"given":"Tatiana","family":"Besschetnova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Nustad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ominsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Mitlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Hattersley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"Bouxsein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Lanske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2019.04.025_bb0005","first-page":"106","article-title":"Abaloparatide","volume":"13","author":"Gonnelli","year":"2016","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.bone.2019.04.025_bb0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2015-1726","article-title":"Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling","volume":"157","author":"Hattersley","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2019.04.025_bb0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2019.04.025_bb0020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.mayocp.2016.10.009","article-title":"Eighteen months of treatment with subcutaneous abaloparatide followed by 6 months of treatment with alendronate in postmenopausal women with osteoporosis: results of the ACTIVExtend trial","volume":"92","author":"Cosman","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bone.2019.04.025_bb0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00198-017-4323-6","article-title":"Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption","volume":"29","author":"Doyle","year":"2018","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2019.04.025_bb0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bone.2016.11.027","article-title":"One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats","volume":"95","author":"Varela","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.04.025_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jbmr.3003","article-title":"One year of abaloparatide, a selective activator of the PTH1 receptor, increased bone formation and bone mass in osteopenic ovariectomized rats without increasing bone resorption","volume":"32","author":"Varela","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.04.025_bb0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.beem.2013.04.010","article-title":"Osteoporosis in older men: recent advances in pathophysiology and treatment","volume":"27","author":"Laurent","year":"2013","journal-title":"Best Practice Res Clinical Endocrinol Metabol"},{"key":"10.1016\/j.bone.2019.04.025_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/boneres.2014.1","article-title":"Osteoporosis in men: a review","volume":"2","author":"Adler","year":"2014","journal-title":"Bone Res"},{"key":"10.1016\/j.bone.2019.04.025_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00198-006-0254-3","article-title":"Bone loss in elderly men: increased endosteal bone loss and stable periosteal apposition. The prospective MINOS study","volume":"18","author":"Szulc","year":"2007","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2019.04.025_bb0055","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI10942","article-title":"Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men","volume":"106","author":"Falahati-Nini","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2019.04.025_bb0060","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0090-4295(01)01342-5","article-title":"A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer","volume":"58","author":"McLeod","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.bone.2019.04.025_bb0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2019.04.025_bb0070","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","article-title":"Longitudinal effects of aging on serum total and free testosterone levels in healthy men","volume":"86","author":"Harman","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2019.04.025_bb0075","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2265.2012.04432.x","article-title":"Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study","volume":"77","author":"Sartorius","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bone.2019.04.025_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4602129","article-title":"Male hypogonadism and osteoporosis: the effects, clinical consequences, and treatment of testosterone deficiency in bone health","volume":"2017","author":"Golds","year":"2017","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.bone.2019.04.025_bb0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1210\/jc.2006-1375","article-title":"A population-level decline in serum testosterone levels in American men","volume":"92","author":"Travison","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2019.04.025_bb0090","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1210\/jc.2003-030200","article-title":"Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study","volume":"88","author":"Szulc","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2019.04.025_bb0095","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2019.04.025_bb0100","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","article-title":"Mortality after all major types of osteoporotic fracture in men and women: an observational study","volume":"353","author":"Center","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2019.04.025_bb0105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"Haentjens","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bone.2019.04.025_bb0110","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00198-005-1950-0","article-title":"The near absence of osteoporosis treatment in older men with fractures","volume":"16","author":"Feldstein","year":"2005","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2019.04.025_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.04.025_bb0120","doi-asserted-by":"crossref","first-page":"20200","DOI":"10.1074\/jbc.RA118.004751","article-title":"Parathyroid hormone(1-34) and its analogs differentially modulate osteoblastic Rankl expression via PKA\/SIK2\/SIK3 and PP1\/PP2A-CRTC3 signaling","volume":"293","author":"Ricarte","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2019.04.025_bb0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00223-018-0422-4","article-title":"Abaloparatide exerts one anabolic effects with less stimulation of bone resorption-related factors: a comparison with teriparatide","volume":"103","author":"Makino","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2019.04.025_bb0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bone.2009.06.011","article-title":"Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin","volume":"45","author":"Li","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.04.025_bb0135","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2009.05.024","article-title":"Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats","volume":"45","author":"Proell","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.04.025_bb0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2018.10.012","article-title":"Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption","volume":"120","author":"Chandler","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.04.025_bb0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry nomenclature committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.04.025_bb0150","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.04.025_bb0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.04.025_bb0160","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1715546","article-title":"Apalutamide treatment and metastasis-free survival in prostate cancer","volume":"378","author":"Smith","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2019.04.025_bb0165","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00223-005-0158-9","article-title":"Osteoblast dysfunction in male idiopathic osteoporosis","volume":"78","author":"Pernow","year":"2006","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2019.04.025_bb0170","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00223-009-9239-5","article-title":"Bone histomorphometry in male idiopathic osteoporosis","volume":"84","author":"Pernow","year":"2009","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2019.04.025_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1359\/jbmr.2001.16.1.157","article-title":"Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys","volume":"16","author":"Burr","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.04.025_bb0180","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/jbmr.3036","article-title":"Romosozumab improves bone mass and strength while maintaining bone quality in ovariectomized cynomolgus monkeys","volume":"32","author":"Ominsky","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.04.025_bb0185","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bone.2016.11.004","article-title":"Effects of abaloparatide-SC (BA058) on bone histology and histomorphometry: the ACTIVE phase 3 trial","volume":"97","author":"Moreira","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.04.025_bb0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bone.2011.03.769","article-title":"Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody","volume":"49","author":"Kostenuik","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2019.04.025_bb0195","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1359\/jbmr.060506","article-title":"Dimensions and volumetric BMD of the proximal femur and their relation to age among older U.S. men","volume":"21","author":"Marshall","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.04.025_bb0200","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s00198-005-1876-6","article-title":"Intermittently administered parathyroid hormone 1-34 reverses bone loss and structural impairment in orchiectomized adult rats","volume":"16","author":"Gabet","year":"2005","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2019.04.025_bb0205","first-page":"215","article-title":"Long-term effects of aging and orchidectomy on bone and body composition in rapidly growing male rats","volume":"1","author":"Ke","year":"2001","journal-title":"J. Musculoskelet. Neuronal Interact."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219301620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219301620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:44:02Z","timestamp":1757612642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219301620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":41,"alternative-id":["S8756328219301620"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.04.025","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}